Pharmicell Co., Ltd. (KRX:005690)
South Korea · Delayed Price · Currency is KRW 10,930
-180 (-1.62%)
Sep 1, 2026, 3:30 PM KST
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 666.64 billion as of September 1, 2026. Its market cap has decreased by -0.27% in one year.
Market Cap
666.64B
Enterprise Value
n/a
Revenue
23.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,930.00
ChartMarket Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 666.64B, an increase of 1,527.55%. That is a compound annual growth rate of 9.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 666.64B | -23.54% |
| Dec 30, 2025 | 871.86B | 75.48% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Onconic Therapeutics | 818.70B |
| Chabiotech | 746.50B |
| Komipharm International | 673.50B |
| Hyundai Bioscience | 634.99B |
| GI Innovation | 527.74B |
| AbClon | 490.82B |
| GC Corp. | 455.38B |
| Medy-Tox | 449.06B |